Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-bacterial monoclonal antibodies: next generation therapy against superbugs
Hui Wang, Daijie Chen, Huili Lu
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 11, pp. 3957-3972
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Alternative therapeutic strategies to treat antibiotic-resistant pathogens
Craig R. MacNair, Steven T. Rutherford, Man‐Wah Tan
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 262-275
Closed Access | Times Cited: 89
Effective remediation and phytotoxicity assessment of oxytetracycline and Cd co-contaminated soil using biochar
Junmei Qin, Jiaxin Li, Huanhuan Pei, et al.
Environmental Technology & Innovation (2024) Vol. 35, pp. 103649-103649
Open Access | Times Cited: 9
Monoclonal Antibodies as a Therapeutic Strategy against Multidrug-Resistant Bacterial Infections in a Post-COVID-19 Era
Hsiao-Chun Chen, Yu-Ling Pan, Ying Chen, et al.
Life (2024) Vol. 14, Iss. 2, pp. 246-246
Open Access | Times Cited: 8
Nanomaterials as multimodal photothermal agents (PTAs) against ‘Superbugs’
Shubham Roy, Jhilik Roy, Bing Guo
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 11, pp. 2287-2306
Closed Access | Times Cited: 19
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy
Susanna Esposito, Gayatri Amirthalingam, Matteo Bassetti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Antibody–Antimicrobial Conjugates for Combating Antibiotic Resistance
Luofeng Yu, Zifang Shang, Qizhe Jin, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 1
Closed Access | Times Cited: 20
Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of Treponema pallidum BamA (TP0326)
Mary R. Ferguson, Kristina N. Delgado, Shannon McBride, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Enhancing host defense against Brucella: The immune effect exerted by anti-OMP16 monoclonal antibody
Yunyi Zhai, Hui Wang, Kaihui Sun, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114142-114142
Closed Access
Redirecting the host immune response to bacterial infection with antibody-recruiting molecules (ARMs)
Priscilla Dzigba, Misago D. Seth, Mallary C. Greenlee‐Wacker, et al.
Current Opinion in Chemical Biology (2025) Vol. 86, pp. 102585-102585
Closed Access
Antimicrobial Management in the Intensive Care Unit
Gabrielle Gibson, Lauren Kolodziej, Sarah Matuszak, et al.
(2025), pp. 1383-1423
Closed Access
Antibiotic conjugates: Using molecular Trojan Horses to overcome drug resistance
Xi Li, Siyuan Dong, Qi Pan, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118007-118007
Closed Access
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Andrew A. Almonte, Simon Thomas, Laurence Zitvogel
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 7
Closed Access
Immunotherapies for the prevention and treatment of Staphylococcus aureus infections: updates and challenges
Pooi Yin Chung
Pathogens and Disease (2023) Vol. 81
Closed Access | Times Cited: 7
Mechanism-guided strategies for combating antibiotic resistance
Shengwei Sun, Xueyingzi Chen
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 10
Closed Access | Times Cited: 2
Pulmonary Pharmacokinetics of Antibody and Antibody Fragments Following Systemic and Local Administration in Mice
Prabhas Jagdale, Ashwni Verma, Dhaval K. Shah
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 2
A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections
Mohammadreza Rahimian, Davoud Jafari-Gharabaghlou, Elham Mohammadi, et al.
PHAGE (2024) Vol. 5, Iss. 4, pp. 203-222
Closed Access | Times Cited: 2
Antibacterial activity of a silver-incorporated vancomycin-modified mesoporous silica against methicillin-resistant Staphylococcus aureus
Mehdi Chamani, Shadi Asgari, Ali Najmeddin, et al.
Journal of Biomaterials Applications (2024) Vol. 39, Iss. 5, pp. 439-454
Closed Access | Times Cited: 1
Chemical strategies for antisense antibiotics
Mathijs Pals, Alf A. Lindberg, Willem A. Velema
Chemical Society Reviews (2024)
Open Access | Times Cited: 1
Novel broadly reactive monoclonal antibody protects against Pseudomonas aeruginosa infection
Margalida Mateu-Borrás, Spencer R. Dublin, Jason Kang, et al.
Infection and Immunity (2024) Vol. 93, Iss. 1
Open Access | Times Cited: 1
Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
Mingya Cao, Siyu Wang, Shaohao Zhou, et al.
mSphere (2024)
Open Access | Times Cited: 1
Discovery of novel tetrahydrobenzothiophene derivatives as MSBA inhibitors for antimicrobial agents
Shuchen Pei, Lin Lai, Wanlin Sun, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106932-106932
Closed Access | Times Cited: 3
The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics
Marta K. Ruest, Jonathan J. Dennis
Pathogens (2022) Vol. 11, Iss. 8, pp. 931-931
Open Access | Times Cited: 3
Nanocluster-antibody-drug conjugates (NADC) as an intravesical precision theranostic agent for interstitial cystitis
Zhijun Lin, Wanyan Wang, Dingxin Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Antibody-based therapy: an alternative for antimicrobial treatment in the post-antibiotic era
Liang Luo, Qing Li, Xing Chen, et al.
Microbiological Research (2024) Vol. 290, pp. 127974-127974
Closed Access
Exploring immunotherapy to control human infectious diseases
Praveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati
Advances in protein chemistry and structural biology (2024), pp. 389-429
Closed Access
Page 1 - Next Page

Scroll to top